Table 5.

Dose-effect relationship among sUA levels, clinical prognosis and severity of coronary artery disease

	137～315 µmol/L	316～387 µmol/L	388～446 µmol/L	347～659 µmol/L	P value
Coronary angiography
Non-culprit lesion vessel occlusion, n (%)	5 (4.7)	9 (8.4)	10 (9.6)	17 (16.2)	0.041
Multi-vessel coronary artery disease, n (%)	19 (17.9)	24 (22.4)	31 (29.8)	37 (35.2)	0.022
Gensini score, (mean±SD)	16.96±10.35	19.31±10.63	26.12±11.48	33.33±14.01	<0.001
One-year follow-up total MACEs
Total MACEs, n (%)	14 (13.2)	15 (14.2)	36 (34.6)	43 (41)	<0.001

MACEs, major adverse cardiovascular events; sUA, serum uric acid.